ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 153 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,212,000 | +29.1% | 214,108 | -3.6% | 0.02% | +25.0% |
| Q1 2018 | $939,000 | -19.5% | 222,102 | +1.8% | 0.02% | -20.0% |
| Q4 2017 | $1,167,000 | +65.8% | 218,106 | +38.2% | 0.02% | +66.7% |
| Q3 2017 | $704,000 | -9.7% | 157,859 | -1.6% | 0.01% | -7.7% |
| Q2 2017 | $780,000 | -34.4% | 160,460 | -2.3% | 0.01% | -40.9% |
| Q1 2017 | $1,189,000 | +27.6% | 164,177 | +0.7% | 0.02% | +22.2% |
| Q4 2016 | $932,000 | -62.1% | 163,004 | -15.3% | 0.02% | -60.9% |
| Q3 2016 | $2,462,000 | -3.3% | 192,338 | -5.9% | 0.05% | -13.2% |
| Q2 2016 | $2,546,000 | +67.3% | 204,323 | +12.2% | 0.05% | +55.9% |
| Q1 2016 | $1,522,000 | +56.3% | 182,044 | +85.1% | 0.03% | +47.8% |
| Q4 2015 | $974,000 | -20.5% | 98,365 | -1.5% | 0.02% | -20.7% |
| Q3 2015 | $1,225,000 | -17.8% | 99,895 | +2.8% | 0.03% | -14.7% |
| Q2 2015 | $1,491,000 | -11.2% | 97,195 | -1.2% | 0.03% | -10.5% |
| Q1 2015 | $1,679,000 | – | 98,340 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
| Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
| PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
| First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
| ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
| Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |